Composite renal endpoints: was ACCOMPLISH accomplished?
Heerspink
Hiddo Lambers
HL
Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, Netherlands.
de Zeeuw
Dick
D
D017311:Amlodipine / Q000008:administration & dosage; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001552:Benzazepines / Q000008:administration & dosage; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D003404:Creatinine / Q000097:blood; D018450:Disease Progression; D004232:Diuretics / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005919:Glomerular Filtration Rate; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000503:physiopathology*; D012084:Renin-Angiotensin System / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001552:Benzazepines; D002121:Calcium Channel Blockers; D004232:Diuretics; D006852:Hydrochlorothiazide; D017311:Amlodipine; D003404:Creatinine; C044946:benazepril